DNTH (Dianthus Pharma) Gross Margin

Official company branding of Dianthus Corp (DNTH)

The share of gross income in revenue correlates with the dependence of Dianthus Therapeutics (DNTH) on insurance reimbursements for the treatment of rare pathologies, with 85.70 serving as the current metric level. The business foundation relies on academic R&D research conducted by immunologists. However, the lack of independent pricing power during the early stages of development leaves the company vulnerable and entirely dependent on external venture capital investments.

DNTH - Dianthus Corp Return on Gross Profit over the range 02/21/2024 - 11/20/2026

Comprehensive metric breakdowns and analytics for Dianthus Corp (DNTH)

Basic company analysis:DNTH - Dianthus Pharma
Manufactured products of Dianthus Pharma

Dianthus Therapeutics (DNTH), which is developing innovative antibodies for the therapy of autoimmune pathologies, is currently in a phase of intense competition for patent superiority. By analyzing the gross margin share, an investor assesses the efficiency of covering direct production costs, which determines the capital intensity of the asset and the fundamental stability of the business. The stable trend of this metric confirms the company's ability to scale development without a critical increase in cost of goods sold.

Key competitors

argenx - Gross Profit Rate|Gross Profitability biontech.de|ABIVAX (ABVX) - Return on Sales by Gross Profit|Gross Margin ADMA|Gross Profit Ratio PTGX|Gross Profitability Immunovant Corp IMVT|Gross Margin Kiniksa Pharmaceuticals, Ltd. KNSA|GRFS - Gross Profitability|Return on Sales by Gross Profit Adaptive Biotechnologies ADPT|CLDX (Celldex Therapeutics, Inc.) - Return on Gross Profit|Aurinia Pharmaceuticals Inc. (AUPH) - Gross Margin|Return on Gross Profit BCRX|Gross Profit Margin Vera Therapeutics Inc VERA|Gross Profitability Pharvaris Pharma (PHVS)|Gross Margin AbCellera Corp (ABCL)|Gross Margin TRML (Tourmaline Bio Inc)|Return on Sales by Gross Profit precigen.com (PGEN)|PHAR - Gross Profitability|Gross Profit Rate NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio Corp) - Return on Gross Profit|Zenas Corp (ZBIO) - Gross Margin|Return on Gross Profit IMNM|GOSS: Gross Profit Rate|Gross Profitability KalVista Pharma (KALV)|SEPN - Gross Profit Margin|Gross Margin PVLA (pieris.com)|Gross Margin Savara Pharma SVRA|RIGL: Return on Gross Profit|ANAB - Gross Margin|ATXS: Gross Margin|ENGN - Return on Sales by Gross Profit|Return on Gross Profit RAPT|JBIO (Aerovate Therapeutics Inc) - Gross Profit Ratio|Gross Margin ACRS|Return on Gross Profit kyvernatx.com KYTX|Gross Margin TLSA (Tiziana Life Sciences, Ltd.)|Gross Margin Cabaletta Bio CABA|VTYX: Return on Gross Profit|Theratechnologies Inc. (THTX) - Return on Gross Profit|AVTX: Gross Margin|ELDN - Return on Sales by Gross Profit|AGEN (Agenus, Inc) - Gross Margin|Gross Margin Climb Bio, Inc.|Gross Profitability Zura Bio Limited (ZURA)|ATYR (aTyr Pharmaceuticals) - Gross Profit Rate|Gross Margin ADAG (Adagene Inc)|IMA - Return on Gross Profit|STTK - Gross Profitability|EQ (equilliumbio.com) - Gross Return on Sales|CNTB: Gross Margin|Immunic Inc (IMUX) - Gross Margin|ATRA (Atara Biotherapeutics Inc) - Gross Margin|Gross Return on Sales IFRX (InflaRx N.V.)|x4pharma.com (XFOR) - Gross Profit Rate|Adicet Bio, Inc. - Gross Return on Sales|Celularity Inc - Return on Gross Profit|Gross Margin INmune Bio Corporation INMB|Barinthus Biotherapeutics - Gross Margin|Kezar Life Sciences, Inc. (KZR) - Return on Gross Profit|SAB Biotherapeutics Inc. (SABS) - Gross Profitability|Return on Gross Profit Akari Therapeutics plc|Gross Profitability enlivex.com|q32bio.com (QTTB) - Return on Sales by Gross Profit|Gross Margin GOVX|Edesa Biotech, Inc. - Gross Return on Sales|iBio Inc - Return on Gross Profit|Gross Margin Carisma Therapeutics CARM|XTLB - Gross Profitability|BOLT (boltbio.com) - Gross Return on Sales|HCWB: Gross Margin|Aptevo (APVO) - Gross Margin|Gross Profitability AIM ImmunoTech|Return on Gross Profit Aditxt (ADTX)|Return on Gross Profit GRI (GRI Bio Corporation)|XORTX - Gross Return on Sales|Gross Margin HIND (Vyome Holdings Inc.)|Gross Profit Rate REVB|Indaptus - Gross Margin|SCNI (Scinai Immunotherapeutics Ltd.) - Gross Return on Sales|CALI: Gross Margin|Affimed NV - Gross Profit Rate|Gross Profitability Allakos Inc.|Gross Margin HOOKIPA Pharma|Gross Profitability IGM Biosciences, Inc. (IGMS)|ITOS - Gross Profit Margin|Gross Margin OCEA (Ocean Bio)|Gross Profit Rate TCBP|THRD - Gross Profitability